Additionally, DHH-RHEBL1-positive patients showed a distinctive gene expression signature both with respect to CBFA2T3-GLIS2-positive patients (518 differentially expressed genes; P<0.05), and CN-AML patients (596 differentially expressed genes; P<0.05). This evidence concerns the gene DHH and acute myeloid leukemia.